CAS 1354235-96-3: (1R,3S)-1-[3-[[4-(2-Fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
Formula:C30H31FN4O3
InChI:InChI=1S/C30H31FN4O3/c1-38-27-11-10-19(16-20(27)18-34-12-14-35(15-13-34)26-9-5-3-7-23(26)31)28-29-22(17-25(33-28)30(36)37)21-6-2-4-8-24(21)32-29/h2-11,16,25,28,32-33H,12-15,17-18H2,1H3,(H,36,37)/t25-,28+/m0/s1
InChI key:InChIKey=FUHCEERDBRGPQZ-LBNVMWSVSA-N
SMILES:O=C(O)C1NC(C2=CC=C(OC)C(=C2)CN3CCN(C=4C=CC=CC4F)CC3)C=5NC=6C=CC=CC6C5C1
- Synonyms:
- 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-[3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-, (1R,3S)-
- (1R,3S)-1-[3-[[4-(2-Fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | trans-Ned 19 REF: IN-DA009FWYCAS: 1354235-96-3 | 98% | To inquire | Tue 04 Mar 25 |
![]() | trans-Ned-19 REF: TR-N388750CAS: 1354235-96-3 | - - - | 256.00 €~1,707.00 € | Mon 14 Apr 25 |
![]() | trans-Ned 19 REF: TM-T12205LCAS: 1354235-96-3 | 98% | 71.00 €~1,244.00 € | Tue 22 Apr 25 |
![]() | trans-Ned 19 REF: 3D-EEC23596CAS: 1354235-96-3 | Min. 95% | - - - | Discontinued product |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
trans-Ned 19
Ref: IN-DA009FWY
5mg | 318.00 € | ||
10mg | 645.00 € | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
trans-Ned-19
Controlled ProductRef: TR-N388750
5mg | 256.00 € | ||
10mg | 467.00 € | ||
50mg | 1,707.00 € |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
trans-Ned 19
Ref: TM-T12205L
25mg | 637.00 € | ||
50mg | 827.00 € | ||
100mg | 1,244.00 € |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
trans-Ned 19
Ref: 3D-EEC23596
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |